Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,096 | -20,621 | -8,422 | -4,644 | -14,185 |
| Depreciation Amortization | 93 | 8,706 | 48 | 24 | 103 |
| Income taxes - deferred | -444 | -444 | N/A | N/A | -1,675 |
| Accounts payable and accrued liabilities | 605 | 359 | -318 | -321 | 951 |
| Other Working Capital | 356 | 240 | -609 | -738 | 1,469 |
| Other Operating Activity | 8,983 | 284 | 796 | 502 | -215 |
| Operating Cash Flow | $-14,502 | $-11,476 | $-8,504 | $-5,176 | $-13,553 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $4 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 33,296 | 33,296 | 33,296 | 33,296 | 18,873 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -982 |
| Financing Cash Flow | $33,296 | $33,296 | $33,296 | $33,296 | $17,891 |
| Beginning Cash Position | 18,516 | 18,516 | 18,516 | 18,516 | 14,177 |
| End Cash Position | 37,314 | 40,335 | 43,308 | 46,635 | 18,516 |
| Net Cash Flow | $18,798 | $21,820 | $24,792 | $28,119 | $4,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,502 | -11,476 | -8,504 | -5,176 | -13,553 |
| Free Cash Flow | -14,502 | -11,476 | -8,504 | -5,176 | -13,553 |